News
Becton Dickinson & Co. stock underperforms Thursday when compared to competitors despite daily gains
This was the stock's third consecutive day of gains.
Becton Dickinson (NYSE:BDX) has recently announced the appointment of Bilal Muhsin as Executive Vice President, tasked with leading the company's future Connected Care segment. Despite this ...
This was the stock's third consecutive day of losses.
BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced that, effective ...
Goldman Sachs analyst David Roman reiterated a Sell rating on Medtronic today and set a price target of $78.00. The company’s shares closed today at $89.92. Take advantage of TipRanks Premium at 50% ...
A high-level overview of Becton, Dickinson and Company (BDX) stock. View (BDX) real-time stock price, chart, news, analysis, analyst reviews and more.
Enteral Feeding Devices Market worth US$3,994.2 million by 2030 with 6.0% CAGR | MarketsandMarkets™.
The global enteral feeding devices market, valued at US$2,807.9 million in 2024, stood at US$2,965.1 million in 2025 and is ...
Review the current Becton Dickinson & Co (BDX:XNYS) growth, profitability and efficiency, financial health, and cash flow key metrics to decide if BDX is the best investment for you.
BCC Research announces the release of its "2024 Diagnostics Research Review," shining a spotlight on the significant growth ...
Read about Becton Dickinson & Co (BDX:XNYS) stock and today's latest news and financial updates.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results